The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Bisson Sabine

Reporting owner CIK 0002152874 · CHIEF OPERATING OFFICER

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Bisson SabineBisson SabineBisson Sabine · October 13, 2026 · Conversion · Common StockBisson Sabine · October 13, 2026 · Conversion · Common StockOct 13, 2026Oct 13, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

2 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 13, 2026Retension Pharmaceuticals, Inc.Common StockBisson SabineConversion
Oct 13, 2026Retension Pharmaceuticals, Inc.Common StockBisson SabineConversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Retension Pharmaceuticals, Inc.RTSN · company listings
Bisson SabineCHIEF OPERATING OFFICER
ConversionCommon StockNon-derivative security · Code C2,504Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Retension Pharmaceuticals, Inc.RTSN · company listings
Bisson SabineCHIEF OPERATING OFFICER
ConversionCommon StockNon-derivative security · Code C1,611Not reported *Value: Not reportedCurrency not specifiedView ↗